Previous Article | Next Article 
Infection and Immunity, November 1999, p. 5799-5805, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Evaluation of a Truncated Recombinant Flagellin
Subunit Vaccine against Campylobacter jejuni
Lanfong H.
Lee,1
Edward
Burg III,1
Shahida
Baqar,1
A. L.
Bourgeois,1
Don H.
Burr,1,2
Cheryl P.
Ewing,1
Trevor J.
Trust,3 and
Patricia
Guerry1,*
Enteric Diseases Program, Naval Medical
Research Center, Bethesda, Maryland 20889-56071;
Food and Drug Administration, Beltsville, Maryland
207082; and Department of Biochemistry
and Microbiology, University of Victoria, Victoria, British
Columbia V8W 3P6, Canada3
Received 5 May 1999/Returned for modification 7 July 1999/Accepted 16 August 1999
A recombinant protein comprising the maltose-binding protein (MBP)
of Escherichia coli fused to amino acids 5 to 337 of the FlaA flagellin of Campylobacter coli VC167 was evaluated
for immunogenicity and protective efficacy against challenge by a
heterologous strain of campylobacter, Campylobacter jejuni
81-176, in two murine models. The sequence of the flaA gene
of strain 81-176 revealed a predicted protein which was 98.1% similar
to that of VC167 FlaA over the region expressed in the fusion protein.
Mice were immunized intranasally with two doses of 3 to 50 µg of
MBP-FlaA, given 8 days apart, with or without 5 µg of the mutant
E. coli heat-labile enterotoxin (LTR192G) as a
mucosal adjuvant. The full range of MBP-FlaA doses were effective in
eliciting antigen-specific serum immunoglobulin G (IgG) responses, and
these responses were enhanced by adjuvant use, except in the highest
dosing group. Stimulation of FlaA-specific intestinal secretory IgA
(sIgA) responses required immunization with higher doses of MBP-FlaA
(
25 µg) or coadministration of lower doses with the adjuvant. When
vaccinated mice were challenged intranasally 26 days after
immunization, the best protection was seen in animals given 50 µg of
MBP-FlaA plus LTR192G. The protective efficacies of this
dose against disease symptoms and intestinal colonization were 81.1 and
84%, respectively. When mice which had been immunized with 50 µg of
MBP-FlaA plus LTR192G intranasally were challenged orally
with 8 × 1010, 8 × 109, or 8 × 108 cells of strain 81-176, the protective efficacies
against intestinal colonization at 7 days postinfection were 71.4, 71.4, and 100%, respectively.
*
Corresponding author. Mailing address: Naval Medical
Research Center, National Naval Medical Center, 8901 Wisconsin Ave., Bethesda, MD 20889-5607. Phone: (301) 319-7662. Fax: (301) 319-7679. E-mail: guerryp{at}nmripo.nmri.nnmc.navy.mil.
Infection and Immunity, November 1999, p. 5799-5805, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Joslin, S. N., Hendrixson, D. R.
(2009). Activation of the Campylobacter jejuni FlgSR Two-Component System Is Linked to the Flagellar Export Apparatus. J. Bacteriol.
191: 2656-2667
[Abstract]
[Full Text]
-
Hobb, R. I., Fields, J. A., Burns, C. M., Thompson, S. A.
(2009). Evaluation of procedures for outer membrane isolation from Campylobacter jejuni. Microbiology
155: 979-988
[Abstract]
[Full Text]
-
Janssen, R., Krogfelt, K. A., Cawthraw, S. A., van Pelt, W., Wagenaar, J. A., Owen, R. J.
(2008). Host-Pathogen Interactions in Campylobacter Infections: the Host Perspective. Clin. Microbiol. Rev.
21: 505-518
[Abstract]
[Full Text]
-
Baqar, S., Applebee, L. A., Gilliland, T. C. Jr., Lee, L. H., Porter, C. K., Guerry, P.
(2008). Immunogenicity and Protective Efficacy of Recombinant Campylobacter jejuni Flagellum-Secreted Proteins in Mice. Infect. Immun.
76: 3170-3175
[Abstract]
[Full Text]
-
Roy, K., Hamilton, D., Allen, K. P., Randolph, M. P., Fleckenstein, J. M.
(2008). The EtpA Exoprotein of Enterotoxigenic Escherichia coli Promotes Intestinal Colonization and Is a Protective Antigen in an Experimental Model of Murine Infection. Infect. Immun.
76: 2106-2112
[Abstract]
[Full Text]
-
Saha, S., Takeshita, F., Matsuda, T., Jounai, N., Kobiyama, K., Matsumoto, T., Sasaki, S., Yoshida, A., Xin, K.-Q., Klinman, D. M., Uematsu, S., Ishii, K. J., Akira, S., Okuda, K.
(2007). Blocking of the TLR5 Activation Domain Hampers Protective Potential of Flagellin DNA Vaccine. J. Immunol.
179: 1147-1154
[Abstract]
[Full Text]
-
Mansfield, L. S., Bell, J. A., Wilson, D. L., Murphy, A. J., Elsheikha, H. M., Rathinam, V. A. K., Fierro, B. R., Linz, J. E., Young, V. B.
(2007). C57BL/6 and Congenic Interleukin-10-Deficient Mice Can Serve as Models of Campylobacter jejuni Colonization and Enteritis. Infect. Immun.
75: 1099-1115
[Abstract]
[Full Text]
-
Fernandez, S., Palmer, D. R., Simmons, M., Sun, P., Bisbing, J., McClain, S., Mani, S., Burgess, T., Gunther, V., Sun, W.
(2007). Potential Role for Toll-Like Receptor 4 in Mediating Escherichia coli Maltose-Binding Protein Activation of Dendritic Cells. Infect. Immun.
75: 1359-1363
[Abstract]
[Full Text]
-
Glynn, A., Roy, C. J., Powell, B. S., Adamovicz, J. J., Freytag, L. C., Clements, J. D.
(2005). Protection against Aerosolized Yersinia pestis Challenge following Homologous and Heterologous Prime-Boost with Recombinant Plague Antigens. Infect. Immun.
73: 5256-5261
[Abstract]
[Full Text]
-
Cuadros, C., Lopez-Hernandez, F. J., Dominguez, A. L., McClelland, M., Lustgarten, J.
(2004). Flagellin Fusion Proteins as Adjuvants or Vaccines Induce Specific Immune Responses. Infect. Immun.
72: 2810-2816
[Abstract]
[Full Text]
-
Wilson, D. L., Bell, J. A., Young, V. B., Wilder, S. R., Mansfield, L. S., Linz, J. E.
(2003). Variation of the natural transformation frequency of Campylobacter jejuni in liquid shake culture. Microbiology
149: 3603-3615
[Abstract]
[Full Text]
-
Sahin, O., Zhang, Q., Meitzler, J. C., Harr, B. S., Morishita, T. Y., Mohan, R.
(2001). Prevalence, Antigenic Specificity, and Bactericidal Activity of Poultry Anti-Campylobacter Maternal Antibodies. Appl. Environ. Microbiol.
67: 3951-3957
[Abstract]
[Full Text]